Navigation Links
LSUHSC study reports racial/ethnic differences in young people with cancer
Date:8/23/2013

New Orleans, LA Mei-Chin Hsieh, MSPH, CTR, of LSU Health Sciences Center New Orleans School of Public Health's Louisiana Tumor Registry, is the lead author of a study that reports racial and ethnic differences in the incidence of soft tissue sarcomas in adolescents and young adults. The research, conducted at LSU Health Sciences Center New Orleans School of Public Health, is published online in the Journal of Adolescent and Young Adult Oncology: http://online.liebertpub.com/doi/abs/10.1089/jayao.2012.0031.

The LSUHSC research team, which also included Xiao-Cheng Wu, MD, MPH, Director of the LSUHSC Louisiana Tumor Registry, Patricia Andrews, MPH, Instructor of Epidemiology, and Vivien Chen, PhD, Professor of Epidemiology, analyzed 1995-2008 incidence data from 25 population-based cancer registries covering 64% of the United States population, which they obtained from the North American Association of Central Cancer Registries.

The incidence rates of soft tissue sarcoma types in cancer patients who are 15 to 29 years old vary among racial/ethnic groups. The incidence of all soft tissue sarcomas combined was 34% higher in males than females, 60% higher among African-Americans than Caucasians, and slightly higher among Hispanics than Caucasians. The researchers found that African-American and Hispanic males had a higher incidence of Kaposi sarcoma than Caucasians. For non-Kaposi sarcoma, African-Americans had a significantly higher incidence of fibromatous tumors and rhabdomyosarcoma than Caucasians, Hispanics had a significantly higher incidence of liposarcoma, and Caucasians were more likely to be diagnosed with synovial sarcoma than African-Americans.

"Most studies on adolescents and young adults aged 15 to 29 have focused on the comparison of this age group with younger and/or older populations with less focus on quantifying the differences among racial/ethnic groups within this age group," notes Hsieh. The National Cancer Institute defines soft tissue sarcoma as a cancer that begins in the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. There are a number of different types. They include Kaposi sarcoma, a malignancy that occurs in blood vessel walls that often affects people with immune deficiencies, such as HIV/AIDS; fibrosarcoma tumors in fibrous tissue in the arms, legs, or trunk; liposarcoma tumors in fatty tissue, often in the legs and trunk; rhabdomyosarcoma cancer that occurs in skeletal muscle; and synovial sarcoma cancer in the tissue around the joints and ankles.

This type of research provides information that can improve care. It raises awareness of the need for inclusion of cancer patients in this age group in clinical trials. It alerts physicians to the racial/ethnic disparities for different cancers. It can also direct policy. For instance, policies could be implemented to prevent Kaposi sarcoma since it is the only type among all soft tissue sarcomas that is amenable to prevention through appropriate interventions. Further efforts should focus on developing effective racially and ethnically sensitive and culturally acceptable interventions in order to minimize the disparities and ultimately reduce the incidence of Kaposi sarcoma in young adults of all races/ethnicities.

While disparities are also observed for common non-Kaposi sarcoma types, no well-established cancer controls are currently in place. Unlike Kaposi sarcoma, factors for racial and ethnic disparities in non-Kaposi sarcoma incidence among adolescents and young adults are less clear. More research on factors contributing to the racial and ethnic disparities of non-Kaposi sarcomas is needed.

"We hope that, based on our study results, more attention will be paid to all aspects of cancer care for this age group," Hsieh concludes. The research is a special study of the LSU Health Sciences Center New Orleans School of Public Health's Louisiana Tumor Registry, which is one of the 18 competitively awarded cancer registries in the SEER (Surveillance, Epidemiology and End Results) Program of the National Cancer Institute. The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States. LSUHSC's Louisiana Tumor Registry is also a member of the North American Association of Central Cancer Registries.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. LA Tumor Registry at LSUHSC receives $1.3 million from NCI
2. LSUHSC Dental School awarded $1.8 million for HIV care and education
3. LSUHSC research adds new info to improve pediatric dental sedation
4. LSUHSCs Hollier one of few ever awarded coveted national lectureship
5. LSUHSC paper judged best of the year
6. 8th edition of LSUHSC facultys textbook published
7. LSUHSC research reveals Rx target for HPV, Hep C and related cancers
8. LSUHSC research discoveries shed light on common STI
9. LSUHSC research provides new drug target for Her-2 related breast cancer
10. LSUHSC research finding keys to future obesity & related diseases
11. LSUHSCs Tilton awarded prestigious Hower Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
(Date:2/8/2016)... ... 08, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to a ... derived from a cluster of melanin when exposed to sunlight. Although most moles are ... lifetime of embarrassment. Historically, mole removal has involved a painful, often expensive ...
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... The ... held annually in this country. The AutismOne 2016 Conference, which is being held May ... they often won’t hear elsewhere about helpful interventions and causes of chronic illness in ...
(Date:2/7/2016)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, 2016 , ... ... Friday in recognition of National Wear Red Day. National Wear Red Day is ... and stroke in women. Heart disease and stroke cause 1 in 3 deaths among ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 Vestagen Technical ... high performance apparel for healthcare and other demanding applications, ... Chief Executive Officer. He replaces Dale Pfost , ... Chairman. Mr. Bold is also joining Vestagen,s Board of ... new class of active barrier technologies that combines fluid ...
(Date:2/8/2016)... YORK, Pa. , Feb. 8, 2016  Unilife Corporation ... developer and supplier of injectable drug delivery systems, today announced ... and six months ended December 31, 2015 after market close ... not scheduled a conference call to discuss these financial results.  ... About Unilife Corporation --> About Unilife ...
(Date:2/8/2016)... -- Astellas Pharma Inc. President and Chief Executive Officer Yoshihiko ... as president, Americas Operations, for Astellas US LLC, with ... South America , effective April 1, 2016.  Robinson previously ... in the United States -- a ... , who is retiring in June 2016.  --> ...
Breaking Medicine Technology: